GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » Inventories, Inventories Adjustments

Curatis Holding AG (CHIX:CURNZ) Inventories, Inventories Adjustments : CHF0.00 Mil (As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Curatis Holding AG Inventories, Inventories Adjustments?

Curatis Holding AG's Inventories, Inventories Adjustments for the quarter that ended in Jun. 2024 was CHF0.00 Mil.


Curatis Holding AG Inventories, Inventories Adjustments Historical Data

The historical data trend for Curatis Holding AG's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG Inventories, Inventories Adjustments Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23
Inventories, Inventories Adjustments
- - -

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Inventories, Inventories Adjustments Get a 7-Day Free Trial - - - - -

Curatis Holding AG Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.


Curatis Holding AG Business Description

Industry
Traded in Other Exchanges
Address
Weierweg 7, Liestal, CHE, CH-4410
Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.

Curatis Holding AG Headlines

No Headlines